New combo therapy targets Hard-to-Treat breast cancers
Disease control
Recruiting now
This study tests a new two-drug combination for people with advanced breast cancer that has spread or cannot be removed by surgery. The drugs aim to boost the immune system to attack cancer cells while delivering chemotherapy directly to them. About 50 participants will receive t…
Phase: PHASE1, PHASE2 • Sponsor: Marengo Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC